Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Working With Veterans Organizations to Improve Blood Pressure (POWER)

6. April 2015 aktualisiert von: US Department of Veterans Affairs
The primary purpose of this project is to establish the efficacy of a novel peer support intervention to reduce hypertension among members of veteran service organizations (VSOs). Specifically, we plan to demonstrate that veterans participating in a peer support intervention, as opposed to a purely didactic educational program, will have better blood pressure (BP) control, increased engagement in blood pressure lowering activities (such as exercise), and a more active stance as patients.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Detaillierte Beschreibung

IMPACT ON VETERANS HEALTH It is anticipated that this intervention will help participating veterans achieve optimal hypertension (HTN) control. Doing so will reduce their risks for heart disease and stroke, and improve their quality of life. It is hoped that the collaborative nature of this intervention will strengthen the Department of Veterans Affairs (VA)'s ties to the veteran community, and establish important "partnerships for health." If successful, this intervention could serve as a model for managing chronic disease both within and outside the VA system.

BACKGROUND/RATIONALE Despite consensus that effective hypertension treatment reduces morbidity and mortality, many patients in the United States continue to have suboptimal blood pressure control. Even with the provider resources and motivated patients inherent in a randomized clinical trial, over a third of patients participating in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) were not at their goal blood pressure of 140/90 after five years. Similarly, within the Veterans Integrated Service Network (VISN) 12 we have found that as many as 30% of patients with hypertension are above the target BP of 140/90, despite routine physician reminders to patients who are above these goals. Moreover, preliminary results of an internally funded randomized trial suggest minimal impact of further physician-focused interventions to reduce patients' blood pressure.

OBJECTIVES We will have two primary objectives. First, because the intervention proposed is novel, we believe we need to demonstrate its efficacy in a methodologically rigorous fashion. Specifically we plan to demonstrate that veterans participating in a peer support intervention will have improved blood pressure control, knowledge of blood pressure treatment, both generally and for themselves, and a more active stance as patients.

Second, we will carefully examine the process by which our intervention achieves these goals, including examining such key structural variables as the frequency of peer support meetings, attendance of participants at these meetings, and use of healthcare professional support by the group leaders. As part of this second objective, we also seek to understand the fidelity with which the peer leaders are to deliver the intervention, and the satisfaction of both support group participants and leaders with the intervention.

METHODS There are three primary activities in the present project.

First, academicians from the Clement J. Zablocki VA Medical Center (VAMC) are working with the Veterans of Foreign Wars (VFW) and other community groups to develop a community-academic partnership that follows the principles of community-based participatory research. This key activity is underway and will continue beyond the present period of funding. Second, the centerpiece of the present grant is a cluster randomized clinical trial (RCT) of the use of peer-led support groups to improve BP control in patients with hypertension. Fifty posts drawn from the VFW, American Legion, Vietnam Veterans Association, and National Association of Black Veterans will be randomly assigned to receive professionally delivered education regarding hypertension or to a peer support intervention. The third activity is an evaluation of the processes involved in delivering the peer support intervention that will allow for successful replication, or to provide insight into why the expected improvement in BP control did not occur.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

404

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Wisconsin
      • Milwaukee, Wisconsin, Vereinigte Staaten, 53295-1000
        • Clement J. Zablocki VA Medical Center, Milwaukee, WI

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind
  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  1. Member of a post or auxiliary of a participating veterans' service organization or Elks Lodge in the 70 miles surrounding the Milwaukee VAMC.
  2. Hypertension as established by one of: a) Average systolic blood pressure (SBP) greater than 140 or diastolic blood pressure (DBP) greater than 90 at two baseline visits; b) SBP greater than 130 or DBP greater than 90 at two baseline visits, plus patient report of diabetes mellitus and use of a hypoglycemic agent at the baseline visit; or c) self-reported hypertension plus self-reported current treatment with at least one antihypertensive drug at baseline visit.
  3. Willingness to sign informed consent document.

Exclusion Criteria:

  1. Medical or social condition preventing routine attendance at a monthly meeting.
  2. Inability to communicate with other post members because of language barrier or physical limitation (e.g., prior stroke).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Peer Led
Post provided with blood pressure cuffs, pedometers and scale. Two post members trained as peer leaders who encourage post members to take positive steps to improve BP. Peer leader training involves 20 hours of training over 12 months, telephone/email access to clinical experts and educational materials to share with post members.
Post provided with blood pressure cuffs, pedometers and scale. Two post members trained as peer leaders who encourage post members to take positive steps to improve BP. Peer leader training involves 20 hours of training over 12 months, telephone/email access to clinical experts and educational materials to share with post members.
Andere Namen:
  • Peer led education and support
Aktiver Komparator: Seminar
Post provided with blood pressure cuffs, pedometers and scale. Post members, including study participants invited to didactic sessions on cardiovascular health.
Post provided with blood pressure cuffs, pedometers and scale. Post members, including study participants invited to didactic sessions on cardiovascular health.
Andere Namen:
  • Professional didactic education

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Systolic Blood Pressure
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Mean/Standard Error (SE) change in systolic blood pressure
9/16/2008-8/9/2010; baseline and 12 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Diastolic Blood Pressure
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Mean/SE change in diastolic blood pressure
9/16/2008-8/9/2010; baseline and 12 months
Change in Weight
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Mean/SE change in weight, measured in pounds (lbs)
9/16/2008-8/9/2010; baseline and 12 months
Change in BMI
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Mean/SE change in Body Mass Index (BMI) (kg/m2)
9/16/2008-8/9/2010; baseline and 12 months
Change in Health Status
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Response to the question "How would you rate your general health status?". Response options are scored as follows.

  1. Excellent
  2. Very Good
  3. Good
  4. Fair
  5. Poor We report the change in health status from baseline to 12 months.
9/16/2008-8/9/2010; baseline and 12 months
Change in Time Since Last Physician Visit
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Change in mean # of months since last visit to a physician
9/16/2008-8/9/2010; baseline and 12 months
Non-Clinic Blood Pressure Checks
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
% reporting non-clinic blood pressure (BP) checks at least once a month
9/16/2008-8/9/2010; baseline and 12 months
Change in Number of Blood Pressure Medications
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Change in mean # of prescription blood pressure medications
9/16/2008-8/9/2010; baseline and 12 months
Change in Hypertension Knowledge
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Hypertension Evaluation of Lifestyle and Management (HELM) Construct: Knowledge of hypertension and lifestyle factors related to hypertension Minimum Score: 0 Maximum Score: 14 Interpretation of Score: Higher is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Hypertension Attitudes
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Not applicable; series of agree/disagree statements that we wrote Construct: Attitudes around blood pressure diagnosis, treatment (including lifestyle changes), and seriousness of the condition Minimum Score: 12 Maximum Score: 60 Interpretation of Score: Lower is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Satisfaction With Blood Pressure Treatment
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Modified Holmes-Ravnor Satisfaction with Decision (SWD) Construct: Satisfaction with current blood pressure treatment Minimum Score: 1 Maximum Score: 5 Interpretation of Score: Lower is better (NOTE: Original instrument's scoring is reversed; i.e., higher is better)

9/16/2008-8/9/2010; baseline and 12 months
Change in Alcohol Use
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Alcohol Use Disorders Identification Test (AUDIT) Construct: Alcohol use and abuse Minimum Score: 0 Maximum Score: 12 Interpretation of Score: Lower is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Sodium Intake
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Hopkins Dietary Questionnaire (only the dietary salt avoidance questions) Construct: Dietary sodium intake Minimum Score: 2 Maximum Score: 12 Interpretation of Score: Higher is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Physical Activity Level
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: International Physical Activity Questionnaire (IPAQ), Metabolic Equivalent of Task (MET) Construct: Total metabolic equivalents (a measure of energy expenditure) in the last 7 days Minimum Score: 0 Maximum Score: Not applicable; based on physical activity done Interpretation of Score: Higher is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Daily Steps
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Mean/SE change in # of steps per day (self report)
9/16/2008-8/9/2010; baseline and 12 months
Change in Fruit and Vegetable Intake
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months
Mean/SE change in # of servings per day; questions taken from the 2009 Behavioral Risk Factor Surveillance System (BRFSS) Questionnaire
9/16/2008-8/9/2010; baseline and 12 months
Change in Medication Adherence
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Morisky Adherence; questions modified to ask specifically about blood pressure medication Construct: Adherence to prescribed medication-taking regimen Minimum Score: 0 Maximum Score: 4 Interpretation of Score: Lower is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Self Efficacy
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Schwarzer General Perceived Self-Efficacy Construct: Perceived self-efficacy Minimum Score: 10 Maximum Score: 40 Interpretation of Score: Higher is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Social Support
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in overall score on:

Scale: Medical Outcomes Study (MOS) Social Support Survey Construct: Overall measure of social support, including tangible, affectionate, positive social interaction, and emotional/informational Minimum Score: 0 Maximum Score: 100 Interpretation of Score: Higher is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Health Opinions
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in overall score on:

Scale: Krantz Health Opinion Survey Construct: Opinions about healthcare and healthcare providers Minimum Score: 0 Maximum Score: 16 Interpretation of Score: Higher is better

9/16/2008-8/9/2010; baseline and 12 months
Change in Patient Activation
Zeitfenster: 9/16/2008-8/9/2010; baseline and 12 months

Mean/SE change in score on:

Scale: Hibbard Patient Activation Measure (PAM) Construct: Level of patient activation and engagement in health care Minimum Score: 0 Maximum Score: 100 Interpretation of Score: Lower is better (NOTE: Original instrument's scoring is reversed; i.e., higher is better)

9/16/2008-8/9/2010; baseline and 12 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. Februar 2008

Primärer Abschluss (Tatsächlich)

1. August 2010

Studienabschluss (Tatsächlich)

1. Dezember 2010

Studienanmeldedaten

Zuerst eingereicht

7. Dezember 2007

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. Dezember 2007

Zuerst gepostet (Schätzen)

11. Dezember 2007

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Schätzen)

24. April 2015

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

6. April 2015

Zuletzt verifiziert

1. August 2014

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren